Matches in SemOpenAlex for { <https://semopenalex.org/work/W2282163774> ?p ?o ?g. }
- W2282163774 endingPage "1115" @default.
- W2282163774 startingPage "1108" @default.
- W2282163774 abstract "Sequential therapy posed a high risk of emergence of multidrug resistance and presented a management issue in chronic hepatitis B (CHB) treatment. We evaluated the antiviral efficacy and safety of entecavir (ETV) plus tenofovir (TDF) combination therapy in multidrug-resistant (MDR) CHB patients.In this prospective, multicentre study, MDR CHB patients, defined as measurable serum HBV DNA (≥60 IU/ml) while on any rescue treatment regimen for at least 24 weeks and the presence of documented prior genotypic resistance to both nucleoside analogue(s) and nucleotide analogue, were treated with ETV 1.0 mg and TDF 300 mg combination therapy for 48 weeks.A total of 64 eligible patients who had previously failed to a median three lines of antiviral therapy (range, 2-6) were included. At baseline, median age was 47.0 years, 89.1% were HBeAg(+), and median HBV DNA was 4.24 (range, 2.11-6.73) log10 IU/ml. By week 4, 12, 24 and 48, 15/64 (23.4%), 36/64 (56.3%), 43/64 (67.2%) and 55/64 (85.9%) patients achieved a HBV DNA <60 IU/ml respectively. The mean reduction of HBV DNA from baseline to 4 and 48 weeks was 1.23 log10 IU/ml and 2.38 log10 IU/ml respectively. Although five patients experienced virological breakthrough, all were transient and no resistant mutation to TDF or novel mutation was detected in any patients.In difficult-to-treat MDR CHB patients with a high exposure to multiple antiviral drugs, ETV plus TDF combination therapy can provide a very high rate of viral suppression through 48 weeks of treatment." @default.
- W2282163774 created "2016-06-24" @default.
- W2282163774 creator A5006412769 @default.
- W2282163774 creator A5023448208 @default.
- W2282163774 creator A5037098078 @default.
- W2282163774 creator A5037540651 @default.
- W2282163774 creator A5049575773 @default.
- W2282163774 creator A5055770656 @default.
- W2282163774 creator A5059260037 @default.
- W2282163774 creator A5067074791 @default.
- W2282163774 date "2016-02-07" @default.
- W2282163774 modified "2023-10-01" @default.
- W2282163774 title "Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study" @default.
- W2282163774 cites W112572118 @default.
- W2282163774 cites W1976104517 @default.
- W2282163774 cites W1984567379 @default.
- W2282163774 cites W2005021102 @default.
- W2282163774 cites W2014500655 @default.
- W2282163774 cites W2025530770 @default.
- W2282163774 cites W2031317669 @default.
- W2282163774 cites W2048759891 @default.
- W2282163774 cites W2071476028 @default.
- W2282163774 cites W2075091804 @default.
- W2282163774 cites W2089873940 @default.
- W2282163774 cites W2097595967 @default.
- W2282163774 cites W2100938842 @default.
- W2282163774 cites W2110109022 @default.
- W2282163774 cites W2120667564 @default.
- W2282163774 cites W2124316479 @default.
- W2282163774 cites W2126362543 @default.
- W2282163774 cites W2141332320 @default.
- W2282163774 cites W2142557452 @default.
- W2282163774 cites W2163577777 @default.
- W2282163774 cites W2325799013 @default.
- W2282163774 cites W2915810710 @default.
- W2282163774 cites W4211026375 @default.
- W2282163774 doi "https://doi.org/10.1111/liv.13059" @default.
- W2282163774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26781724" @default.
- W2282163774 hasPublicationYear "2016" @default.
- W2282163774 type Work @default.
- W2282163774 sameAs 2282163774 @default.
- W2282163774 citedByCount "19" @default.
- W2282163774 countsByYear W22821637742016 @default.
- W2282163774 countsByYear W22821637742017 @default.
- W2282163774 countsByYear W22821637742018 @default.
- W2282163774 countsByYear W22821637742019 @default.
- W2282163774 countsByYear W22821637742020 @default.
- W2282163774 countsByYear W22821637742021 @default.
- W2282163774 countsByYear W22821637742023 @default.
- W2282163774 crossrefType "journal-article" @default.
- W2282163774 hasAuthorship W2282163774A5006412769 @default.
- W2282163774 hasAuthorship W2282163774A5023448208 @default.
- W2282163774 hasAuthorship W2282163774A5037098078 @default.
- W2282163774 hasAuthorship W2282163774A5037540651 @default.
- W2282163774 hasAuthorship W2282163774A5049575773 @default.
- W2282163774 hasAuthorship W2282163774A5055770656 @default.
- W2282163774 hasAuthorship W2282163774A5059260037 @default.
- W2282163774 hasAuthorship W2282163774A5067074791 @default.
- W2282163774 hasConcept C114851261 @default.
- W2282163774 hasConcept C126322002 @default.
- W2282163774 hasConcept C133936738 @default.
- W2282163774 hasConcept C159047783 @default.
- W2282163774 hasConcept C188816634 @default.
- W2282163774 hasConcept C2522874641 @default.
- W2282163774 hasConcept C2775940106 @default.
- W2282163774 hasConcept C2776175608 @default.
- W2282163774 hasConcept C2776999253 @default.
- W2282163774 hasConcept C2777382497 @default.
- W2282163774 hasConcept C2777410769 @default.
- W2282163774 hasConcept C2777869810 @default.
- W2282163774 hasConcept C2779344132 @default.
- W2282163774 hasConcept C2780593183 @default.
- W2282163774 hasConcept C2781413609 @default.
- W2282163774 hasConcept C3013748606 @default.
- W2282163774 hasConcept C71924100 @default.
- W2282163774 hasConcept C86803240 @default.
- W2282163774 hasConcept C89423630 @default.
- W2282163774 hasConcept C90924648 @default.
- W2282163774 hasConceptScore W2282163774C114851261 @default.
- W2282163774 hasConceptScore W2282163774C126322002 @default.
- W2282163774 hasConceptScore W2282163774C133936738 @default.
- W2282163774 hasConceptScore W2282163774C159047783 @default.
- W2282163774 hasConceptScore W2282163774C188816634 @default.
- W2282163774 hasConceptScore W2282163774C2522874641 @default.
- W2282163774 hasConceptScore W2282163774C2775940106 @default.
- W2282163774 hasConceptScore W2282163774C2776175608 @default.
- W2282163774 hasConceptScore W2282163774C2776999253 @default.
- W2282163774 hasConceptScore W2282163774C2777382497 @default.
- W2282163774 hasConceptScore W2282163774C2777410769 @default.
- W2282163774 hasConceptScore W2282163774C2777869810 @default.
- W2282163774 hasConceptScore W2282163774C2779344132 @default.
- W2282163774 hasConceptScore W2282163774C2780593183 @default.
- W2282163774 hasConceptScore W2282163774C2781413609 @default.
- W2282163774 hasConceptScore W2282163774C3013748606 @default.
- W2282163774 hasConceptScore W2282163774C71924100 @default.
- W2282163774 hasConceptScore W2282163774C86803240 @default.
- W2282163774 hasConceptScore W2282163774C89423630 @default.
- W2282163774 hasConceptScore W2282163774C90924648 @default.